Francis Barth

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Murielle Rinaldi‐Carmona, Francis Barth, Michel Héaulme et al. · FEBS Letters · 1994 · 1.7K citations · Full text

Pharmacotherapy, Experimental Pharmacology, Cannabinoid Pharmacology +18

SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor

M Rinaldi-Carmona, Francis Barth, J Millan et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 704 citations · Full text

A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1

Monsif Bouaboula, Sylvie Perrachon, Laura Milligan et al. · Journal of Biological Chemistry · 1997 · 459 citations · Full text

Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist

Murielle Rinaldi‐Carmona, Francis Barth, Michel Héaulme et al. · Life Sciences · 1995 · 300 citations

Cannabis Use, Molecular Pharmacology, Functional Selectivity +14

Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain

Murielle Rinaldi‐Carmona, Françoise Pialot, Christian Congy et al. · Life Sciences · 1996 · 131 citations

Cannabis Use, Rodent Brain, Functional Selectivity +12